E-LIB Suche - Ergebnisse für: Percent, Ivor J

1

Phase II study investigating the efficacy and safety of gle..:

Hong, David S. ; Cappuzzo, Federico ; Chul Cho, Byoung...
Lung Cancer. 190 (2024) - p. 107512 , 2024

2

Safety and efficacy of nivolumab plus ipilimumab in patient..:

Tykodi, Scott S ; Gordan, Lucio N ; Alter, Robert S...
Journal for ImmunoTherapy of Cancer. 10 (2022) 2 - p. e003844 , 2022

Link: https://doi.org/10.1136/..

3

Phase Ib/II Study of Enzalutamide with Samotolisib (LY30234..:

Sweeney, Christopher J. ; Percent, Ivor J. ; Babu, Sunil...
Clinical Cancer Research. 28 (2022) 11 - p. 2237-2247 , 2022

Link: https://doi.org/10.1158/..

4

Safety and efficacy of nivolumab plus ipilimumab in patient..:

Emamekhoo, Hamid ; Olsen, Mark R. ; Carthon, Bradley C....
Cancer. 128 (2021) 5 - p. 966-974 , 2021

Link: https://doi.org/10.1002/..

5

P2.06-017 Amethyst NSCLC Trial: Phase 2 Study of MGCD265 in..:

Bazhenova, Lyudmila ; Kim, Dong-Wan ; Cavanna, Luigi...
Journal of Thoracic Oncology. 12 (2017) 1 - p. S1080-S1081 , 2017

Link: https://doi.org/10.1016/..

6

Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Comb..:

Forero-Torres, Andres ; Saleh, Mansoor N. ; Galleshaw, Janice A....
Clinical Breast Cancer. 10 (2010) 4 - p. 275-280 , 2010

Link: https://doi.org/10.3816/..

7

Pretargeted Radioimmunotherapy (RIT) with a Novel Anti-TAG-..:

Forero-Torres, Andres ; Shen, Sui ; Breitz, Hazel...
Cancer Biotherapy and Radiopharmaceuticals. 20 (2005) 4 - p. 379-390 , 2005

Link: https://doi.org/10.1089/..

8

Phase Ib/II Study of Enzalutamide with Samotolisib (LY30234..:

Sweeney, Christopher J ; Percent, Ivor J ; Babu, Sunil...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9662871/. , 2022

Link: http://www.ncbi.nlm.nih...

9

Telaglenastat Plus Everolimus in Advanced Renal Cell Carcin..:

Lee, Chung-Han ; Motzer, Robert ; Emamekhoo, Hamid...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202043/. , 2022

Link: http://www.ncbi.nlm.nih...

10

Safety and efficacy of nivolumab plus ipilimumab in patient..:

Tykodi, Scott S ; Gordan, Lucio N ; Alter, Robert S...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8883262/. , 2022

Link: http://www.ncbi.nlm.nih...

11

Nivolumab and Ipilimumab as Maintenance Therapy in Extensiv..:

Owonikoko, Taofeek K ; Park, Keunchil ; Govindan, Ramaswamy...
http://hdl.handle.net/10668/17328. , 2021

Link: http://hdl.handle.net/10..

12

Safety and efficacy of nivolumab plus ipilimumab in patient..:

Emamekhoo, Hamid ; Olsen, Mark R ; Carthon, Bradley C...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298991/. , 2021

Link: http://www.ncbi.nlm.nih...

13

Nivolumab and Ipilimumab as Maintenance Therapy in Extensiv..:

Owonikoko, Taofeek K ; Park, Keunchil ; Govindan, Ramaswamy...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078251/. , 2021

Link: http://www.ncbi.nlm.nih...

14

Ramucirumab plus docetaxel versus placebo plus docetaxel in..:

Petrylak, Daniel P ; de Wit, Ronald ; Chi, Kim N...
boreal:245945. , 2020

Link: http://hdl.handle.net/20..

15

Ramucirumab plus docetaxel versus placebo plus docetaxel in..:

Petrylak, Daniel P ; de Wit, Ronald ; Chi, Kim N...
boreal:245945. , 2020

Link: http://hdl.handle.net/20..